Dementia and stem cell therapy
The improvements Dr. Celma has seen in communication, attention and engagement, why he encourages early assessment, and his advice to families.
Dr. Celma writes openly about what he sees in his patients, including the limits of what stem cell therapy can do.
The improvements Dr. Celma has seen in communication, attention and engagement, why he encourages early assessment, and his advice to families.
Five questions worth asking any doctor before treatment: your options, safety and quality, benefits and risks, follow-up, and where to verify information.
Read the article: What safety questions to ask before any medical procedure
Edward spent three years in pain before he was diagnosed. How his life changed in the twelve months after umbilical cord MSC therapy.
Read the article: Edward's journey: juvenile idiopathic arthritis
What Dr. Celma has observed in more than 200 patients with Parkinson's disease, why he combines MSCs with GcMAF, and why blood tests and the stage of the disease matter.
Read the article: Parkinson's disease: combining MSCs and GcMAF
How MSCs may calm the autoimmune attack and protect the remaining beta cells, what Dr. Celma has seen over the past two years, and what still needs to be proven.
Read the article: Type 1 diabetes: the promises and challenges of stem cell therapy
From more than 1,000 patients: the changes Dr. Celma looks for in language, communication, eye contact, calmness and coordination, how donors are screened, and the three-dose treatment schedule.
Read the article: Autism and mesenchymal stromal cells (UC-MSCs)
Paula, 57, needed oxygen 24 hours a day and had been told there was no curative approach. Her daughter Sara describes how the family found GcMAF.
Read the article: Hope arrives: a daughter's story of lung cancer and GcMAF
Dr. Celma on GcMAF and stem cells, and two videos about Wes, a boy with autism treated by Dr. Celma, shared with his family's permission.
Video on YouTube, November 2026
A short video for anyone considering stem cell therapy, in which Dr. Celma talks about GcMAF and stem cells.
The video plays from YouTube once you press play.
Video shared by Maryjayne Aria, May 2025
An update on Wes, who recently had his first course of 35 million stem cells in Mexico with Dr. Celma. The changes his mother describes include:
Wes is due to have two further courses of stem cells, alongside GcMAF immunotherapy and molecular oil supplementation.
Video shared by Maryjayne Aria, February 2025
Wes's family tried many therapies to help their son. Maryjayne Aria, who stays in touch with the family, describes how Wes has started to talk, read, count, sing, ride a bike, catch a ball and show empathy, and how he continues to make slow, steady progress.
Send a short description of the condition and Dr. Celma will reply to you personally by email.